Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-26 @ 10:19 PM
Ignite Modification Date:
2025-12-26 @ 10:19 PM
NCT ID:
NCT00842712
Group ID:
EG000
Title:
Safety run-in Part: Cil (1000 mg) + Cetuximab + Cis + Gem
Description:
Cilengitide (Cil) 1000 milligram (mg) intravenous infusion twice weekly over 1 hour on Days 1 and 4 + Cetuximab 400 milligram per square meter (mg/m\^2) intravenous infusion over 2 hours on Day 1 + Cisplatin (Cis) 75 mg/m\^2 intravenous infusion on Day 1 + Gemcitabine (Gem) 1250 mg/m\^2 intravenous infusion on Days 1 and 8 for 3 weeks.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
0
Serious Number At Risk:
3
Other Number Affected:
3
Other Number At Risk:
3
Study:
NCT00842712
Results Section:
NCT00842712
Adverse Events Module:
NCT00842712